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Gallbladder cancer is associated with a dismal progno-
sis, with a 5-year survival rate of \5% for those patients
with disease not amenable to surgery.1,2 In some parts of
the world, the incidence is comparatively high and con-
tributes to a social disaster as a result of its associated poor
outcome. Even among patients who undergo radical sur-
gical resection, the reported median survival across all
stages is 35% to 38%.2,3
The surgical management of gallbladder cancer has
always been controversial. Surgeons across the world have
repeatedly stressed the need for a complete surgical
resection and have demonstrated improved survival in
patients who underwent radical resection.2–6 Guidelines for
the surgical management of gallbladder cancer have been
formulated on the basis of the available evidence.7–9
Despite this, it now appears that one of the biggest prob-
lems in gallbladder cancer is the lack of performance of the
correct surgery in the first place.10–15
An offshoot of the problem of inadequate surgery for
gallbladder cancer is the misuse of the term incidental gall-
bladder cancer and the resulting mismanagement of the
patients included in this group. The term incidental was
coined to denote a histological surprise of gallbladder cancer
in a patient treated with simple cholecystectomy for chole-
cystitis or gallbladder polyps. However, we conducted a study
and found that up to 50% of patients with disease labeled as
incidental gallbladder cancers in the particular series we were
assessing actually had a radiological diagnosis suspicious for
gallbladder cancer, despite which the patients were treated
solely with a simple cholecystectomy.10
Another problem with the surgical management of
gallbladder cancer has been the interchangeable use of the
terms extended, radical, and aggressive surgery when
describing the optimal surgery for gallbladder cancer. Like
any other solid organ cancer, the aim of surgery in gall-
bladder cancer should be to achieve complete tumor
clearance with a stepwise escalation of the extent of radi-
cality determined by on-table surgical acumen coupled
with information gathered preoperatively via imaging.16
Considering that surgery remains the treatment modality
with the best reported outcomes, the worries with regard to
the management of gallbladder cancer are as follows: Is the
algorithm for the management of this cancer unclear? Does
the treatment algorithm need to be more explicit? What can
we do to improve outcomes in gallbladder cancer?
Although the relative incidence of gallbladder cancer
differs widely across countries, the algorithm needs to be
understood by all surgeons treating diseases of the gall-
bladder. In patients with a preoperative diagnosis of
gallbladder cancer, it is imperative that the patient be
treated with a cholecystectomy with en-bloc hepatic
resection with lymphadenectomy with or without bile duct
resection. The extent of the hepatic resection has been
reported to vary from a wedge of the gallbladder bed to
major right lobe of liver resections. Although the debate on
the extent of liver resection continues, the basis for
including the gallbladder as part of the en-bloc resection of
the gallbladder is to prevent desecration of the subserosal
plane of the gallbladder (as is done in a simple cholecys-
tectomy), which could aid tumor cell spread, and also to
include potential micrometastases via the lymphatics of the
gallbladder traversing the gallbladder bed.17 The rationale
for including a bile duct resection should be based on the
cause of the gallbladder cancer, with routine excision of the
bile duct performed for patients with anomalous pancreatic
bile duct junctions. In all other patients, the excision of the
bile duct should be performed only when involved or when
surgically indicated. Such indications include direct bile
duct involvement by the cancer, and positive cystic duct
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margin in which a revision of the margin would entail
encroaching on the bile duct. In addition, the procedure
might be performed to aid lymphadenectomy, especially in
patients undergoing repeat surgery (for incidental gall-
bladder cancer) in which the lymphadenectomy results in
devascularization of the bile duct.
D’Angelica et al., in their recently published analysis on
the effect of the extent of resection on disease-specific
survival and perioperative outcomes, demonstrated poor
outcomes after overaggressive surgeries such as major
hepatectomies and bile duct resections performed when not
clinically indicated.18 This reaffirms the basic oncologic
tenet that cancer survival is determined by tumor biology
and not extent of resection.19
If the results of radiologic investigations are suspicious
for or suggest a potential gallbladder cancer, the patient
should undergo a cholecystectomy with intraoperative fro-
zen section.10 If the diagnosis of malignancy is confirmed, in
tumors that exceed the T1b classification, the procedure
should be completed with a hepatic resection with hepa-
toduodenal lymphadenectomy with or without bile duct
resection.6,9 There is no justification for performing a simple
cholecystectomy in patients with gallbladder cancer who
have tumors classified as greater than T1b—and this mes-
sage needs to be clear. In T1a tumors, a simple
cholecystectomy appears to constitute an adequate resection.
In incidental or missed gallbladder cancers, patients who
have undergone only a simple cholecystectomy and who
have tumors that are stage T1b or more should be con-
sidered for radical repeat resection after a thorough workup
to exclude any evidence of metastasis.6 The use of positron
emission tomography imaging as a complementary tool to
computed tomography of the abdomen has been demon-
strated, especially its use in ruling out metastasis in the
body outside the abdominal cavity.20 Radical repeat
resection in these patients has been shown to be associated
with better survival compared with those who only undergo
a simple cholecystectomy.4
Although long-term outcomes after radical repeat
resection for true incidental gallbladder cancers are
reported to be similar as those of primary radical surgery,
there are no data comparing outcomes of radical repeat
resection in patients whose tumors were truly incidental
compared with patients whose tumors were classified as
missed, potential, or suspicious.
The message is clear: if we want to improve outcomes in
gallbladder cancer, we need to get it right the first time.
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